Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles

The blood–brain barrier (BBB) is highly selective and acts as the interface between the central nervous system and circulation. While the BBB is critical for maintaining brain homeostasis, it represents a formidable challenge for drug delivery. Here we synthesized gold nanoparticles (AuNPs) for targ...

Full description

Saved in:
Bibliographic Details
Published in:Nano letters Vol. 21; no. 22; pp. 9805 - 9815
Main Authors: Li, Xiaoqing, Vemireddy, Vamsidhara, Cai, Qi, Xiong, Hejian, Kang, Peiyuan, Li, Xiuying, Giannotta, Monica, Hayenga, Heather N, Pan, Edward, Sirsi, Shashank R, Mateo, Celine, Kleinfeld, David, Greene, Chris, Campbell, Matthew, Dejana, Elisabetta, Bachoo, Robert, Qin, Zhenpeng
Format: Journal Article
Language:English
Published: United States American Chemical Society 24-11-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The blood–brain barrier (BBB) is highly selective and acts as the interface between the central nervous system and circulation. While the BBB is critical for maintaining brain homeostasis, it represents a formidable challenge for drug delivery. Here we synthesized gold nanoparticles (AuNPs) for targeting the tight junction specifically and demonstrated that transcranial picosecond laser stimulation of these AuNPs post intravenous injection increases the BBB permeability. The BBB permeability change can be graded by laser intensity, is entirely reversible, and involves increased paracellular diffusion. BBB modulation does not lead to significant disruption in the spontaneous vasomotion or the structure of the neurovascular unit. This strategy allows the entry of immunoglobulins and viral gene therapy vectors, as well as cargo-laden liposomes. We anticipate this nanotechnology to be useful for tissue regions that are accessible to light or fiberoptic application and to open new avenues for drug screening and therapeutic interventions in the central nervous system.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
X.L., V.V., and Q.C. designed and performed the experiments and contributed equally to this work. H.X. participated in biodistribution study, tail vein injection and brain tissue processing. P.K. performed the simulation. X.L. participated in initiating the research idea. M.G. and E.D. developed the anti-JAM-A antibodies for this study. H.N.H., S.R.S and E.P. participated in discussion and provided suggestions. C.M. and D.K. developed the protocol for vasomotion study. C.G. and M.C. developed the protocol for tight junction staining and EZ-link biotin detection. R.B. and Z.Q. supervised the project. All authors provided critical feedback and helped shape the research, analysis and manuscript.
Author Contributions
ISSN:1530-6984
1530-6992
DOI:10.1021/acs.nanolett.1c02996